JOHN DEMOPULOS, M.D.
Legal Medicine in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JOHN DEMOPULOS, M.D. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 14,316 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 14K
- Part D claims, 2023
- 89%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JOHN DEMOPULOS, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about JOHN DEMOPULOS, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Legal Medicine compares to other specialties among Texas providers
Legal Medicine share within Texas
Legal Medicine is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
JOHN DEMOPULOS, M.D.'s 2023 MIPS final score plotted against the Legal Medicine national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Legal Medicine) — 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Legal Medicine US NPIs
100/100 MIPS final score — 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Legal Medicine.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JOHN DEMOPULOS, M.D. appears in the CMS NPPES registry as a Legal Medicine provider holding M.D. credentials at 7777 FOREST LN STE B216, DALLAS, TX, 75230, with a listed phone of (972) 566-8380. NPI 1043233604 was issued on 07/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DEMOPULOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 14,316 prescription claims written by this provider, covering 928 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 11% brand-name and 89% generic by claim count, with an opioid prescribing rate of 1.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.
Legal Medicine is a narrow specialty nationwide, with 1,067 enrolled providers across 51 states and an average of 2,821 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1043233604 |
|---|---|
| Specialty | Legal Medicine |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/25/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JOHN DEMOPULOS, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where JOHN DEMOPULOS, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JOHN DEMOPULOS, M.D.. To verify JOHN DEMOPULOS, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
11% brand-name claims vs 89% generic, on 14,316 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 32,880
- Total Day Supply
- 962,171
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $988K
- Generic Drug Cost
- $288K
- Opioid Claims
- 207 (1.4% rate)
- Antibiotic Claims
- 448
Patient Demographics
- Average Patient Age
- 76.2 years
- Avg HCC Risk Score
- 1.13
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 40, 65-74: 372, 75-84: 354, 85+: 162
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JOHN DEMOPULOS, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
652 claims
- Levothyroxine Sodium
Levothyroxine Sodium
615 claims
- Amlodipine Besylate
Amlodipine Besylate
462 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
427 claims
- Losartan Potassium
Losartan Potassium
416 claims
- Gabapentin
Gabapentin
338 claims
- Lisinopril
Lisinopril
327 claims
- Alprazolam
Alprazolam
315 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 652 |
| Levothyroxine Sodium | 615 |
| Amlodipine Besylate | 462 |
| Rosuvastatin Calcium | 427 |
| Losartan Potassium | 416 |
| Gabapentin | 338 |
| Lisinopril | 327 |
| Alprazolam | 315 |
| Tamsulosin Hcl | 305 |
| Metoprolol Succinate | 301 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Legal Medicine Overview
How JOHN DEMOPULOS, M.D. fits within the Legal Medicine landscape nationally.
JOHN DEMOPULOS, M.D.'s 14,316 claims are above the specialty average of 2,821.
Nearby Legal Medicine Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as DEMOPULOS.
Compare Legal Medicine nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is JOHN DEMOPULOS, M.D.'s specialty? ▼
How much does JOHN DEMOPULOS, M.D. prescribe under Medicare Part D? ▼
What is JOHN DEMOPULOS, M.D.'s Medicare quality score? ▼
Where is JOHN DEMOPULOS, M.D. located? ▼
What is JOHN DEMOPULOS, M.D.'s NPI number? ▼
Does JOHN DEMOPULOS, M.D. prescribe more brand-name or generic drugs? ▼
Does JOHN DEMOPULOS, M.D. prescribe opioids? ▼
How many Legal Medicine providers are there in the US? ▼
What drugs does JOHN DEMOPULOS, M.D. prescribe most often? ▼
Does JOHN DEMOPULOS, M.D. accept Medicare? ▼
How can I verify JOHN DEMOPULOS, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology